In a landmark move, the FDA announces a comprehensive policy framework that will help speed development and patient access to innovative therapies. Equally important, this framework outlines the proper development and oversight of regenerative medicine products, including the previously unregulated area of using unproven cellular therapies.
Image: selvanegra/iStock/ThinkStock